Suppressed their PHAstimulated cytokine responses of IL-12, IL-13 and IFN-c followed by a reduction of clinical symptom scores, which is interesting in relation to the findings presented in our study. We should acknowledge the relatively low number of individuals in this study, and the findings need to be confirmed in larger studies. However, we only report results that are consistent at several early time points, thus increasing the probability of true findings. Further, it should be mentioned that results of our in vitro studies are based on the effects of bacterial supernatants that may not represent the in vivo situation in the intestinal tract. In conclusion, we demonstrate that the early infant microbiota associates with the numbers of cytokine-secreting cells at two years of age, in a genus- and species specific manner, which we further confirmed by in vitro stimulations. The early-life gut microbiota could modulate the risk of developing inflammatory conditions like allergic disease. Diabetes mellitus has become one of the most severe endocrine metabolic disorders in the world. Diabetes damages multiple SP600125 JNK inhibitor organs to induce serious complications such as coronary artery disease, renal and ophthalmologic diseases that can result in the disability and mortality for diabetic patients. Liver disease as one of diabetic complications has not been well addressed, but it actually can be very significant. Increasing evidence suggests that among patients with diabetes, the standardized mortality rate from end-stage liver disease is higher than that for cardiovascular disease. The liver plays a pivotal role in glucose homeostasis since it stores glycogen in the fed state and produces glucose through glycogenolysis and gluconeogenesis in the postabsorptive period. Several hormones and metabolic factors engage in the maintenance of glucose homeostasis. In physiological conditions, hepatocytes are the main site of hepatic glucose metabolism. It has been estimated that 30 to 60% of all glucose absorbed in the gastrointestinal tract undergoes hepatic processing with subsequent storage as glycogen or metabolism into amino acids or fatty acids. Insulin and glucagon are two counter-regulatory hormones involved in the regulation of energy metabolism. Insulin enhances glycogen synthesis within the liver and prevents glucose production. Reversely, glucagon induces glucose production and prevents glycogen synthesis. The failure of hepatocytes to respond to insulin induced by diabetes results in uncontrolled gluconeogenesis, glycogenolysis and lipogenesis, promoting hyperglycemia, dyslipidemia and systemic insulin resistance, which will lead to diabetic liver complications such as steatohepatitis, chronic viral hepatitis, and hepatocellular carcinoma. Although insulin resistance is usually associated with the development of type 2 diabetes, it can also be a feature of patients with type 1 diabetes. Insulin resistance has been documented in type 1 diabetes and may contribute to the high risk for cardiovascular disease in this population. In a recent review, it was stated that in type 1 diabetic population, an increased prevalence of obesity and insulin resistance often leads the development of nonalcoholic fatty liver diseases. Zinc is an essential trace element and plays a critical role in cellular integrity and biological functions in respect to cell division, growth, and development. Zn also acts as cofactor for many enzymes and proteins involved in the antioxidant, anti-inflammatory, and anti-apoptotic effects. The liver is important for the regulation of Zn homeostasis, while Zn is necessary for normal hepatic function. Reduced hepatic Zn levels have been correlated with the impaired liver function and regeneration, and it also implicated in both acute and chronic liver disease states.